Gooderham MJ, Kircik LH, Zirwas M, Lee M, Kempers SE, Draelos ZD, Ferris L, Jones TM, Saint-Cyr Proulx E, Bissonnette R, Bhatia N, Guenthner ST, Koppel RA, Welgus H, Merritt C, Elias M, Navale L, Higham RC, Droege M, Berk DR. The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study. J of Skin [Internet]. 2020Oct.27 [cited 2022Jul.1];4(6):s93. Available from: https://www.jofskin.org/index.php/skin/article/view/1063